Cutaneous T-Cell Lymphoma (Conditions)
Related Content
-
Conditions (26):
Squamish Cell Skin Cancer, Mycosis Fungoides, Melanoma, and 23 others
Squamish Cell Skin Cancer, Mycosis Fungoides, Melanoma, Skin Cancer, Cancer, Skin and Hair, Carcinoma in Situ, Lichen Planus, Beckers Nevus, Psoriasis, Lichen Sclerosus, Eczema, dermatitis, Darier's Disease, Neoplasms, Bladder Cancer, Hidradenitis Suppurativa, Sezary Syndrome, Lymphoma, Cancer of bone and connective tissue, Other non-epithelial cancer of skin, Lupus, Inflammatory Linear Verrucous Epidermal Nevus, Epidermal Nevus, Cancer of Head and Neck, Localized Acquired Hypertrichosis [hide]
-
Groups (35):
Cutaneous T-Cell Lymphoma, Melanoma, Eczema, and 32 others
Cutaneous T-Cell Lymphoma, Melanoma, Eczema, Beckers Nevus, Lichen Planus, Lichen Sclerosis, Darier's Disease, Hidradenitis Suppurativa, Granuloma Annulare, Alopecia Areata, Sweet Syndrome, Acne Rosacea, Ovarian Cancer, Large Granular Lymphocyte Leukemia, Liposarcoma, Bladder Cancer, Leiomyosarcoma, Pancreatic Cancer, Astrocytoma, Acute Lymphocytic Leukemia, Burkitt's Lymphoma, Uterine Carcinosarcoma, Esophageal Cancer, Brain Tumors, Cholangiocarcinoma, Inflammatory Breast Cancer, Brain Cancer, Testicular Cancer, Mycosis Fungoides, Lung Cancer, Breast Cancer, Children of Cancer Victims and Survivors, Lymphoma, Chronic Myelogenous Leukemia, Non-Hodgkin's Lymphoma [hide]
-
Symptoms (26):
Decreased DNA Integrity, Granuloma Annulare, Alopecia Areata, and 23 others
Decreased DNA Integrity, Granuloma Annulare, Alopecia Areata, Raynaud's Disease and Phenomenon, red skin rash, Angioedema, Scleroderma, Photosensitizing Activity, Port-Wine Stain, Mole, Cholangiocarcinoma, Burkitt's Lymphoma, abnormal growth and differentiation, Skin Findings, Stomach problem, neoplasm/cancer type, Hypopigmentation, Sclerodactyly, psychological aspect of cancer, Fear of cancer of skin, Klatskin Tumor, Host-Tumor Interaction, Infected finger/toe/paronychia, Concomitant or past diseases, Eye problem, Mental disorders [hide]
-
Treatments (26):
Nucleic Acid Synthesis Inhibitors, Methoxsalen, Methoxsalen 10 MG/ML Topical Solution, and 23 others
Nucleic Acid Synthesis Inhibitors, Methoxsalen, Methoxsalen 10 MG/ML Topical Solution, Methoxsalen 10 MG, METHOXSALEN 1 %, Methoxsalen 10 MG Oral Capsule, Radiation Therapy, Interferon Alfa-2a 3000000 UNT/ML, Interferon Alfa-2a 18000000 UNT, Interferon Alfa-2a 10000000 UNT/ML Injectable Solution, Interferon Alfa-2a 6000000 UNT/ML, INTERFERON ALFA-2A,RECOMBINANT 9MILLION UNT, Interferon Alfa-2a 36000000 UNT/ML, Interferon Alfa-2a, bexarotene, Relaxation of scar or web contracture of skin, Interferon Alfa-2a 3000000 UNT/ML Injectable Solution, Interferon Alfa-2a 6000000 UNT/ML Injectable Solution, Interferon Alfa-2a 18000000 UNT Injectable Solution, Interferon Alfa-2a 36000000 UNT/ML Injectable Solution, Chemotherapy Regimen, hydroquinone 40 MG/ML Topical Cream, DENILEUKIN 150 MCG/ML, BEXAROTENE 1 %, bexarotene 75 MG, DENILEUKIN [hide]
About Cutaneous T-Cell Lymphoma
Cutaneous T-Cell lymphoma (CTCL) is a class of non-Hodgkin's lymphoma, which is a type of cancer of the immune system. Unlike most non-Hodgkin's lymphomas (which are generally B-cell related), CTCL is caused by a mutation of T cells. The malignant T cells in the body are pushed to the surface of the skin in... more 
Cutaneous T-Cell lymphoma (CTCL) is a class of non-Hodgkin's lymphoma, which is a type of cancer of the immune system. Unlike most non-Hodgkin's lymphomas (which are generally B-cell related), CTCL is caused by a mutation of T cells. The malignant T cells in the body are pushed to the surface of the skin in a biological process used to rid the body of offending material, causing various lesions to appear on the skin. These lesions change shape as the disease progresses, typically beginning as what appears to be a rash and eventually forming plaques and tumors before metastatizing to other parts of the body.
Loading... thanks for waiting
Loading... thanks for waiting
Loading... thanks for waiting
There was a problem loading an application. Please try refreshing your browser.
Loading... thanks for waiting
